FDA data Registry peer set 1 peer FDA shortage listed

Alternatives to nystatin

FDA shortage status is active for nystatin; 1 same-class SPL records are listed below for registry comparison only.

View nystatin → All alternatives

Brand: Mycostatin

Polyene Antifungal Prescription 1 alternative found

nystatin class peers while FDA lists an active shortage

nystatin (Mycostatin) is on an FDA shortage listing while 1 other Polyene Antifungal SPL records remain in this registry peer set (class inventory 2). Labeled indication field for nystatin: This medicine treats skin infections caused by Candida, a type of fungus.

Top FAERS reaction fields for nystatin total 14,527 reports across 10 reactions, set beside amphotericin B. Counts are exposure-weighted submissions, not per-patient risk.

About nystatin

Nystatin topical powder is an antifungal medicine. It treats fungal infections on your skin.

Used for: This medicine treats skin infections caused by Candida, a type of fungus. It is for use on the skin only. Do not use in your mouth, vagina, eyes, or for infections inside your body.

View full nystatin profile →

1 Polyene Antifungal peers (wide set)

amphotericin B

Rx

Ambisome, Fungizone

This medicine treats fungal infections like aspergillosis, candidiasis, and cryptococcosis. It can also treat cryptococcal meningitis in people with HIV. It may also be used for visceral leishmaniasis, but this infection can return, especially in those with weak immune systems.

Compare nystatin vs amphotericin B side-by-side →

nystatin vs amphotericin B · FAERS reaction fields

FAERS top-reaction field "Nausea" shows the widest count spread between nystatin and amphotericin B in this extract (1,963-report gap on that field). Counts are exposure-weighted submissions, not prevalence rates.

Side Effect nystatin amphotericin B
Nausea 1,963 -
Fatigue 1,799 -
Diarrhoea 1,786 -
Pneumonia 1,613 576
Dyspnoea 1,483 -
Vomiting 1,326 -
Pain 1,253 -
Death 1,187 516

"-" means no reports for that reaction. Report counts reflect total FAERS submissions, not prevalence rates.

nystatin shortage vs Polyene Antifungal peer index

Shortage status

FDA shortage listing is active for nystatin (status: To Be Discontinued). Peer rows remain a registry index, not a switch guide.

Frequently Asked Questions

Does FDA list a shortage for nystatin while peers remain indexed? ▼
Yes - nystatin matched an active FDA shortage listing (To Be Discontinued) while 1 other Polyene Antifungal SPL records remain in this peer index for field comparison only.

Registry note: Shortage listings and peer indexes are for registry orientation only. This information is for educational purposes only and is not a substitute for professional medical advice. Do not stop or change your medication without talking to your doctor or pharmacist.

Full nystatin profile →

Field note for nystatin: see also the generic vs brand label guide when reading Mycostatin SPL strings.

Read our methodology - how this data is sourced, computed, and verified.